0.44% -0.065

Takeda Pharmaceutical Co Adr (TAK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Takeda Pharmaceutical Co Adr

Healthcare (1154)

@takedapharma

Prossima data di guadagno

Ultimi documenti SEC

TAK's Discussions on Twitter

Confronta TAK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TAK Takeda Pharmaceutical Co Adr	14.81	47.59B	29.96B	957.25M	4.77B	0.304
ZTS Zoetis Inc	154.78	68.78B	9.39B	2.62B	2.22B	5.81
HLN Haleon Plc Adr	9.71	43.40B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	18.00	20.79B	16.70B	-157.13M	1.19B	-0.155
UTHR United Therapeutics Corp	306.06	13.81B	2.99B	1.21B	1.13B	25.06

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-03-16	Aggiornamento	BofA Securities	Neutral → Buy
2022-07-19	Aggiornamento	Cowen	Market Perform → Outperform
2021-10-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-04-19	Downgrade	JP Morgan	Overweight → Neutral
2019-11-01	Iniziato	Cowen	Market Perform
2019-08-15	Downgrade	Daiwa Securities	Outperform → Neutral

Mostra tutto

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

Takeda Pharmaceutical Co Adr Azioni (TAK) Dati Finanziari

Takeda Pharmaceutical Co Adr (TAK)

Takeda Pharmaceutical Co Adr Stock (TAK) Company Profile

Confronta TAK con altri titoli

Takeda Pharmaceutical Co Adr Stock (TAK) Upgrades & Downgrades

Takeda Pharmaceutical Co Adr Borsa (TAK) Ultime notizie

Binge Eating Disorders Global Market Research Report 2025-2035 Featuring Eli Lilly, Amneal, Takeda, Tryp Therapeutics, Tonix, Sumitomo, VIVUS, Novartis, and Pfize - GlobeNewswire Inc.

Japan's Takeda weighs India for global trials to speed up drug launches - MSN

IBD Rating Upgrades: Warrior Met Coal Shows Improved Technical Strength - inkl

IBD Rating Upgrades: Takeda Pharmaceutical ADR Shows Improved Technical Strength - MSN

IBD Rating Upgrades: Ameren Shows Improved Technical Strength - inkl

TAK’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com

Blair William & Co. IL Cuts Stock Position in Takeda Pharmaceutical Co. (NYSE:TAK) - Defense World

Takeda Pharmaceutical Co ADR (TAK) Stock: A Year of Stock Market Dynamics - investchronicle.com

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

The 30-day ADR trend, in yen terms, shows high values for Keyence, Kyocera Corporation Sponsored ADR, and Murata Manufacturing. - 富途牛牛

Takeda Pharma ADR earnings beat by $150.82, revenue fell short of estimates - Investing.com UK

On the 21st, ADR movements in yen terms showed high values for NISSAN MOTOR CO LTD, NINTENDO CO LTD, and Sumitomo Trust. - 富途牛牛

Why This Biotech's Dive Benefits Its Top Three Rivals - Investor's Business Daily

Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK) - Seeking Alpha

Behind Takeda Pharmaceutical Co ADR’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Takeda stock rises after positive Phase 3 results for narcolepsy drug - Investing.com

Takeda stock rises after positive Phase 3 results for narcolepsy drug By Investing.com - Investing.com South Africa

Haleon PLC Sponsored ADR (NYSE:HLN) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World

Takeda Pharmaceutical ADR Earns RS Rating Upgrade - MSN

Nomura Holdings Inc ADR (NYSE:NMR) Shares Acquired by GAMMA Investing LLC - Defense World

Hengan International Group (OTCMKTS:HEGIY) Stock Price Up 3.7% – Time to Buy? - Defense World

Expedia Group Earns RS Rating Upgrade - inkl

GAMMAGARD LIQUID ERC, GAMMAGARD LIQUID and GAMMAGARD S/D U.S. Important Safety Information - Placera.se

Stocks With Rising Relative Price Strength: IREN - inkl

Stocks With Rising Relative Strength: Dr. Reddy's Labs ADR - inkl

Nano Dimension Ltd ADR’s Shares Reel: -28.07% Quarterly Revenue Decline Amid 329.06M Market Cap - investchronicle.com

MNST’s Stock Market Adventure: 19.08% YTD Growth Amidst Volatility - investchronicle.com

On the 10th, the ADR trends show that Takeda Pharmaceutical, Nidec Corporation Sponsored ADR, Advantest, and others are performing well in terms of yen conversion. - 富途牛牛

SEC Form N-CSRS filed by abrdn World Healthcare Fund Shares of Beneficial Interest - Quantisnow

EU approves Takeda’s new Hodgkin lymphoma treatment - Investing.com

IgA nephropathy Pipeline Drugs Analysis 2025: Clinical Trials, - openPR.com

CTVA’s Stock Market Adventure: 22.38% YTD Growth Amidst Volatility - investchronicle.com

Takeda files executive compensation report with SEC - Investing.com

Cameco Earns Relative Strength Rating Upgrade; Hits Key Threshold - inkl

TD Cowen maintains Buy on Takeda, reiterates $16 target - Investing.com

Stocks With Rising Relative Strength: Novartis ADR - inkl

Fidelity Natl Info Svcs Shows Rising Relative Strength; Still Shy Of Key Benchmark - inkl

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus - Wiley Online Library

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Financial Metrics Unveiled: Topgolf Callaway Brands Corp (MODG)’s Key Ratios in the Spotlight - DWinneX

Ratios Reveal: Breaking Down Takeda Pharmaceutical Co ADR (TAK)’s Financial Health - DWinneX

Balance Sheet Insights: Nuveen Churchill Direct Lending Corp (NCDL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Takeda continues stock plan for management in 2025 - Investing.com

Novavax revises Takeda deal for Japan vaccine sales - Investing.com

TAK or DSNKY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction - knoxdaily.com

Takeda Pharmaceutical Co ADR [TAK] Insider Activity: An Update for Investors - knoxdaily.com

Takeda Pharmaceutical Co Adr Azioni (TAK) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a TAK